Literature DB >> 25511517

Funny and late: targeting currents governing heart rate in atrial fibrillation.

James D Daniels1, Joseph A Hill.   

Abstract

Entities:  

Keywords:  atrial fibrillation, funny current; ivabradine; late sodium current; ranolazine; rate control

Mesh：

Substances：

Year:  2015        PMID： 25511517      PMCID： PMC4357534          DOI： 10.1111/jce.12597

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  23 in total

1.  Trends in the pharmacologic management of atrial fibrillation: Data from the Veterans Affairs health system.

Authors:  Mary S Vaughan-Sarrazin; Alexander Mazur; Elizabeth Chrischilles; Peter Cram
Journal:  Am Heart J       Date:  2014-05-02       Impact factor: 4.749

2.  Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.

Authors:  Richard L Verrier; Ana F G Silva; Rodolfo Bonatti; Julio A P Batatinha; Bruce D Nearing; Gongxin Liu; Sridharan Rajamani; Dewan Zeng; Luiz Belardinelli
Journal:  J Cardiovasc Electrophysiol       Date:  2014-12-05

3.  Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).

Authors:  Jeffrey S Borer; Michael Böhm; Ian Ford; Michele Robertson; Michel Komajda; Luigi Tavazzi; Karl Swedberg
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

Review 4.  Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.

Authors:  Nikolaos Fragakis; Konstantinos C Koskinas; Vassilios Vassilikos
Journal:  Pacing Clin Electrophysiol       Date:  2014-08-19       Impact factor: 1.976

5.  Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.

Authors:  James V Freeman; Kristi Reynolds; Margaret Fang; Natalia Udaltsova; Anthony Steimle; Niela K Pomernacki; Leila H Borowsky; Teresa N Harrison; Daniel E Singer; Alan S Go
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-20

6.  Ivabradine in stable coronary artery disease without clinical heart failure.

Authors:  Kim Fox; Ian Ford; Philippe Gabriel Steg; Jean-Claude Tardif; Michal Tendera; Roberto Ferrari
Journal:  N Engl J Med       Date:  2014-08-31       Impact factor: 91.245

7.  Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.

Authors:  Richard L Verrier; Vitor P F Pagotto; Alexandre F Kanas; Marcel F Sobrado; Bruce D Nearing; Dewan Zeng; Luiz Belardinelli
Journal:  Heart Rhythm       Date:  2012-09-14       Impact factor: 6.343

Review 8.  Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis.

Authors:  Gianluigi Savarese; Giuseppe Rosano; Carmen D'Amore; Francesca Musella; Giuseppe Luca Della Ratta; Angela Maria Pellegrino; Tiziana Formisano; Alice Vitagliano; Annapaola Cirillo; Gennaro Cice; Luigi Fimiani; Luca del Guercio; Bruno Trimarco; Pasquale Perrone-Filardi
Journal:  Int J Cardiol       Date:  2013-09-07       Impact factor: 4.164

9.  Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.

Authors:  Sara R Ulimoen; Steve Enger; Jonas Carlson; Pyotr G Platonov; Are H Pripp; Michael Abdelnoor; Harald Arnesen; Knut Gjesdal; Arnljot Tveit
Journal:  Am J Cardiol       Date:  2012-10-27       Impact factor: 2.778

10.  Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.

Authors:  Frank Xavier Scheuermeyer; Eric Grafstein; Rob Stenstrom; Jim Christenson; Claire Heslop; Brett Heilbron; Lorraine McGrath; Grant Innes
Journal:  Acad Emerg Med       Date:  2013-03       Impact factor: 3.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.